Warfarin versus aspirin in preventing tunneled hemodialysis catheter thrombosis: A prospective randomized study

Hong Kong Journal of Nephrology

Volumn 9, Issue 1, 2007, Pages 23-30

  Abdul Rahman, Ibrahiem Saeed ^a   Al Howaish, Abdulla K ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Aspirin; Hemodialysis; Thrombosis; Tunneled central venous catheter; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; TINZAPARIN; WARFARIN;

ADULT; ARTICLE; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETERIZATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEMODIALYSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT OUTCOME; VASCULAR ACCESS;

EID: 34249823990     PISSN: 15615413     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1561-5413(07)60005-2     Document Type: Article

References (52)

1. Windus DW. Permanent vascular access: a nephrologist's view. Am J Kidney Dis 1993;21:457-71.
2. Hakim R, Himmelfarb J. Hemodialysis access failure: a call to action. Kidney Int 1998;54:1029-40.
3. Smits JH, van der Linden J, Blankestijn PJ, Rabelink TJ. Coagulation and haemodialysis access thrombosis. Nephrol Dial Transplant 2000;15:1755-60.
4. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996;7:523-35.
5. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA. Hemodialysis vascular access morbidity in the United States. Kidney Int 1993;43:1091-6.
6. Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990;112:423-8.
7. Boraks P, Seale J, Price J, Bass G, Ethell M, Keeling D, et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 1998;101:483-6.
8. Obialo CI, Conner AC, Lebon LF. Maintaining patency of tunneled hemodialysis catheters - efficacy of aspirin compared to warfarin. Scand J Urol Nephrol 2003;37:172-6.
9. Haire WD, Lieberman RP, Lund GB, Edney JA, Kessinger A, Armitage JO. Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Groshong catheters. Bone Marrow Transplant 1991;7:57-9.
10. NKF-DOQI Clinical Practice Guidelines for Vascular Access. Guideline 23: treatment of tunneled cuffed catheter dysfunction. Am J Kidney Dis 1997;30(Suppl 3):S175-6.
11. Suhocki PV, Conlon PJ Jr, Knelson MH, Harland R, Schwab SJ. Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction. Am J Kidney Dis 1996;28:379-86.
12. Lund GB, Trerotola SO, Scheel PF Jr, Savader SJ, Mitchell SE, Venbrux AC, Osterman FA Jr. Outcome of tunneled hemodialysis catheters placed by radiologists. Radiology 1996;198:467-72.
13. Rysz J, Majewska E, Stolarek RA, Banach M, Cialkowska-Rysz A, Baj Z. Increased levels of soluble TNF-alpha receptors and cellular adhesions molecules in patients undergoing bioincompatible hemodialysis. Am J Nephrol 2006;26:437-44.
14. Agraharkar M, Isaacson S, Mendelssohn D, Muralidharan J, Mustata S, Zevallos G, et al. Percutaneously inserted silastic jugular hemodialysis catheters seldom cause jugular vein thrombosis. ASAIO J 1995;41:169-72.
15. Karnik R, Valentin A, Winkler WB, Donath P, Slany J. Duplex sonographic detection of internal jugular venous thrombosis after removal of central venous catheters. Clin Cardiol 1993;16:26-9.
16. Cox K, Vesely TM, Windus DW. The utility of brushing dysfunctional hemodialysis catheters. JVIR 2000;11:979-83.
17. Uldall R, Besley ME, Thomas A. Maintaining the patency OF double-lumen silastic jugular catheters for hemodialysis. Int J Artif Organs 1993;16:37-40.
18. Zellweger M, Bouchard J, Raymond-Carrier S, Laforest-Renald A, Querin S, Madore F. Systemic anticoagulation and prevention of hemodialysis catheter malfunction. ASAIO J 2005;51:360-5.
19. Merport M, Murphy TP, Egglin TK, Dubel GJ. Fibrin sheath stripping versus catheter exchange for the treatment of failed tunneled hemodialysis catheters: randomized clinical trial. J Vasc Interv Radiol 2000;11:1115-20.
20. O'Farrel LO, Griffith JW, Lang CM. Histologic development of the sheath that forms around long term implanted central venous catheters. J Parenter Enteral Nutr 1996;20:156-8.
21. Haskal ZJ, Leen VH, Thomas-Hawkins C, Shlansky-Goldberg RD, Baum RA, Soulen MC. Transvenous removal of fibrin sheaths from tunneled hemodialysis catheters. J Vasc Interv Radiol 1996; 7:513-7.
22. Di Minno G, Martinez J, McKean ML, De La Rosa J, Burke JF, Murphy S. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Am J Med 1985;79:552-9.
23. Eknoyan G, Brown CHD. Biochemical abnormalities of platelets in renal failure. Evidence of decreased platelet serotonin, adenosine diphosphate and Mg-dependent adenosine triphosphatase. Am J Nephrol 1981;1:17-23.
24. Remuzzi G, Benigni A, Dodesini P, Schieppati A, Livio M, De Gaetano G, et al. Reduced platelet thromboxane formation in uremia. Evidence for functional cyclooxygenase defect. J Clin Invest 1983;71:762-8.
25. Escolar G, Cases A, Bastida E, Garrido M, Lopez J, Revert L, et al. Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa. Blood 1990;76:1336-40.
26. Gawaz MP, Dobos G, Spath M, Schollmeyer P, Gurland HJ, Mujais SK. Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease. J Am Soc Nephrol 1994;5:36-46.
27. Lindahl TL, Lundahl J, Netre C. Studies of the platelet fibrinogen receptor in Glanzmann patients and uremic patients. Thromb Res 1992;67:457-66.
28. Walkowiak B, Pawlowska Z, Michalak E, Cierniewski CS. Expression of fibrinogen receptors on platelets of uremic patients is correlated with the content of GPIIb and plasma level of creatinine. Thromb Haemost 1994;71:164-8.
29. Sreedhara R, Itagaki I, Hakim RM. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors. Am J Kidney Dis 1996;27:355-64.
30. Noris M, Remuzzi G. Uremic bleeding: closing the circle after 30 years of controversies? Blood 1999;94:2569-74.
31. Simon DI, Stamler JS, Loh E, Loscalzo J, Francis SA, Creager MA. Effect of nitric oxide synthase inhibition on bleeding time in humans. J Cardiovasc Pharmacol 1995;26:339-42.
32. Noris M, Remuzzi G. Physiology and pathophysiology of nitric oxide in chronic renal disease. Proc Assoc Am Physicians 1999; 111:602-10.
33. Vaziri ND. Effect of chronic renal failure on nitric oxide metabolism. Am J Kidney Dis 2001;38:S74-9.
34. Deguchi N, Ohigashi T, Tazaki H, Handa M, Ikeda Y. Haemodialysis and platelet activation. Nephrol Dial Transplant 1991;6(Suppl 2):40-2.
35. Reverter JC, Escolar G, Sanz C, Cases A, Villamor N, Nieuwenhuis HK, et al. Platelet activation during hemodialysis measured through exposure of p-selectin: analysis by flow cytometric and ultrastructural techniques. J Lab Clin Med 1994;124:79-85.
36. Viener A, Aviram M, Better OS, Brook JG. Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron 1986;43: 139-43.
37. Shrivastava D, Lundin AP, Dosunmu B, Rao TK, Beyer MM, Friedman EA. Salvage of clotted jugular vein hemodialysis catheters. Nephron 1994;68:77-9.
38. Garofalo RS, Zaleski GX, Lorenz JM, Funaki B, Rosenblum JD, Leef JA. Exchange of poorly functioning tunneled permanent hemodialysis catheters. AJR AM J Roentgenol 1999;173:155-8.
39. Haire WD, Lieberman RP. Thrombosed central venous catheters: restoring function with 6-hour urokinase infusion after failure of bolus urokinase. J Parenter Enteral Nutr 1989;13:92-8.
40. Haire WD, Atkinson JB, Stephens LC, Kotulak GD. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial. Thromb Haemost 1994;72:543-7.
41. Savader SJ, Haikal LC, Ehrman KO, Porter DJ, Oteham AC. Hemodialysis catheter-associated fibrin sheath: treatment with low dose rt-PA infusion. J Vasc Interv Radiol 2000;11:1131-6.
42. Brady PS, Spence LD, Levitin A, Mickolich CT, Dolmatch BL. Efficacy of percutaneous fibrin sheath stripping in restoring patency of tunneled hemodialysis catheters. AJR Am J Roentgenol 1999;173:1023-7.
43. Schon D, Whittman D. Managing the complications of long-term tunneled dialysis catheters. Semin Dial 2003;16:314-22.
44. Beathard GA. Dysfunction of new catheters by old fibrin sheath. Semin Dial 2004;17:243-4.
45. Mokrzycki MH, Jean-Jerome K, Rush H, Zdunek MP, Rosenberg SO. A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int 2001;59:1935-42.
46. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998;9:859-68.
47. Twardowski ZJ. Stepwise anticoagulation with warfarin for prevention of intravenous catheter thrombosis. Hemodial Int 2000; 4:37-41.
48. Sagripanti A, Cupisti A, Baicchi U, Ferdeghini M, Morelli E, Barsotti G. Plasma parameters of the prothrombotic state in chronic uremia. Nephron 1993;63:273-8.
49. Sagedal S, Hartmann A, Sundstrom K, Bjornsen S, Brosstad F. Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets. Nephrol Dial Transplant 2001;16:987-93.
50. Wanner C, Zimmermann J, Quaschning T, Galle J. Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients. Kidney Int 1997;62:S53-5.
51. De Lima JJ, Sesso R, Abensur H, Lopes HF, Giorgi MC, Krieger EM, Pileggi F. Predictors of mortality in long-term haemodialysis patients with a low prevalence of comorbid conditions. Nephrol Dial Transplant 1995;10:1708-13.
52. Rugman FP, Jenkins JA, Duguid JK, Maggs PB, Hay CR. Prothrombin fragment F1 + 2: correlation with cardiovascular risk factors. Blood Coagul Fibrinolysis 1994;5:335-40.